CN104459158B - Aspartate aminotransferase Mitochondria Isoenzyme detection kit - Google Patents

Aspartate aminotransferase Mitochondria Isoenzyme detection kit Download PDF

Info

Publication number
CN104459158B
CN104459158B CN201410805113.9A CN201410805113A CN104459158B CN 104459158 B CN104459158 B CN 104459158B CN 201410805113 A CN201410805113 A CN 201410805113A CN 104459158 B CN104459158 B CN 104459158B
Authority
CN
China
Prior art keywords
buffer
reagent
acid
detection kit
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410805113.9A
Other languages
Chinese (zh)
Other versions
CN104459158A (en
Inventor
邹炳德
邹继华
陆慧贤
黄辛雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meikang biological Polytron Technologies Inc
Original Assignee
NINGBO MEIKANG BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGBO MEIKANG BIOTECHNOLOGY Co Ltd filed Critical NINGBO MEIKANG BIOTECHNOLOGY Co Ltd
Priority to CN201410805113.9A priority Critical patent/CN104459158B/en
Publication of CN104459158A publication Critical patent/CN104459158A/en
Application granted granted Critical
Publication of CN104459158B publication Critical patent/CN104459158B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Disclosure one aspartate aminotransferase Mitochondria Isoenzyme detection kit, consist of: reagent 1: pH of buffer 6.5~8.00.02~0.5mol/L, L-Aspartic acid potassium 0.15~0.3mol/L, malic dehydrogenase 0.3~5KU/L, lactic acid dehydrogenase 0.3~5KU/L, people source cAST antibody 5~20mL/L, antibody stabilization agent 0.01~3%, enzyme stabilizers 0.01~10%, preservative 0.01~1%;Reagent 2: pH of buffer 7.0~9.00.02~0.5mol/L, α-ketoglutaric acid 0.005~0.02mol/L, reduced coenzyme Ⅰ 0.1~0.5mmol/L, preservative 0.01~1%, reduced coenzyme Ⅰ stabilizer 0.01~10%。The advantage with good stability。

Description

Aspartate aminotransferase Mitochondria Isoenzyme detection kit
Technical field
The present invention relates to technical field of medical examination, be specifically related to a kind of aspartate aminotransferase Mitochondria Isoenzyme (m-AST or mAST Mitochondrial form aspartate amino transferase) detection kit。
Background technology
Aspartate aminotransferase (Aspartateaminotransferase, AST) is widely present in the various histiocyte of human body, especially abundant with liver, heart tissue's cell content, and in normal human serum, AST activity is very low。In human body there are two kinds of isozymes in AST, and one is cAST, is mainly derived from cytoplasm, and another kind is mAST, is present in mitochondrion。Both isozymes are variant in genomic constitution, all different in aminoacid composition, immunological characteristic and half-life in vivo etc.。
When the slight pathological changes of body, histiocytic permeability of cell membrane increases, and cAST enters in blood system through cell membrane, but mAST has the protection of two-layer mitochondrial membrane, is not easily released into blood;And when body serious disease, necrocytosis, mitochondrion disintegrate occur, being attached to the mAST on mitochondrion can discharge into rapidly in blood。Therefore, serum mAST activity can reflect histiocytic degree of necrosis, if detecting high level mAST in serum, then shows that cardiac muscle, liver are badly damaged;Additionally the mAST half-life in blood is shorter than cAST, and when cell no longer destroys or repairs, in serum, mAST is quickly down to normal level, and therefore mAST is again the evaluation index of cardiac muscle, liver injury prognosis, and the diagnosis of disease, treatment are had important value。
At present, in serum, mAST measures mainly electrophoresis method, chromatography and immunodepression etc., especially possesses special, accurate, fast and convenient, to can be used for Aulomatizeted Detect advantage with immunodepression, is suitable for the application of clinical extensive specimen。Its Cleaning Principle is: people source cAST antibody forms immune complex with cAST effect in serum sample, make cAST activity inhibited, and mAST activity is unaffected, mAST with the reaction coupling of malic dehydrogenase (MDH) catalysis, can make reduced coenzyme Ⅰ (NADH) be oxidized to NAD+, by detecting the speed that certain wave strong point NADH absorbance declines, can be calculated the activity of mAST。Reaction equation is as follows:
By above-mentioned reaction principle it can be seen that people source cAST antibody is the critical materials of mAST determination of activity system, can people source cAST antibody becomes accurately measure the key of mAST activity in human serum sample。But, according to this area general knowledge, when antibody is with solution state long-term storage, the phenomenons such as the generation that the generation of chemolysis thing, the generation of insoluble agglutinator, solubility associated complex can occur, thus causing that the biological activity of antibody is substantially reduced, therefore antibody is most to save as the best under-20 DEG C of environment, in order to keep the activity of antibody, can only provisional configuration test kit in use, and this is simply not proposed to commercial liquid reagent box。
Summary of the invention
The present invention is directed to the above-mentioned deficiency of prior art, it is provided that the aspartate aminotransferase Mitochondria Isoenzyme detection kit of a kind of excellent in stability。
In order to solve above-mentioned technical problem, the technical solution used in the present invention is: a kind of aspartate aminotransferase Mitochondria Isoenzyme detection kit, and this test kit is made up of following two liquid reagent, wherein:
Reagent 1:
Reagent 2:
Wherein, the described buffer in reagent 1 or 2 can be one or more in TRIS buffer, piperazine-N, N-double; two (2-hydroxyethanesulfonic acid) buffer, N-2-hydroxyethyl piperazine-N '-ethanesulfonic acid buffer, N-tri-(methylol) methylamino-2-hydroxy-propanesulfonic acid buffer, 4-(2-ethoxy)-1-piperazine propane sulfonic acid buffer, 3-morpholine-2-hydroxypropionate sodium buffer;
Described antibody stabilization agent can be the one in glycine and citric acid, glycine and heparin, citric acid and histidine, heparin and histidine combination, the combination of preferred histidine and citric acid, the weight proportion between said sequence combination is: histidine: citric acid=10~100:1;
Described enzyme stabilizers is one or several in trehalose, sucrose, bovine serum albumin, glycerol, Tween 80;
Described preservative is NaN3Or the one in proclin300;
Described reduced coenzyme Ⅰ stabilizer is one or more in trehalose, bovine serum albumin, glycerol, Tween 80。
Advantages of the present invention and beneficial effect: the mAST detection kit of the present invention is by adding antibody stabilization agent, improve in test kit people source cAST antibody in the stability of liquid condition, additionally by combining interpolation enzyme stabilizers and reduced coenzyme Ⅰ stabilizer, therefore more effectively ensure that the stability that test kit is overall, greatly meet the demand of Clinical detection and diagnosis。
Specific embodiment
Below in conjunction with embodiment, the present invention is further described in detail, but is not limited to this。
Embodiment 1
A kind of mAST detection kit, including reagent 1 and reagent 2, wherein:
Reagent 1:
Reagent 2:
Embodiment 2
A kind of mAST detection kit, including reagent 1 and reagent 2, wherein:
Reagent 1:
Reagent 2:
Below the stability of the embodiment of the present invention 1 gained reagent is illustrated。
1, Antibody stability:
Following three group reagents of configuration by the following method:
Organize 1.: recipe configuration reagent described in embodiment 1, and store 18 months in 2~8 DEG C;
Organize 2.: except without antibody stabilization agent, all the other are recipe configuration reagent described in embodiment 1, and store 18 months in 2~8 DEG C;
Group is 3.: after 18 months, the newly configured reagent of formula (antibody of addition be-20 DEG C frozen same a collection of antibody) described in embodiment 1。
Above-mentioned three group reagents are placed on automatic clinical chemistry analyzer, location parameter is set in accordance with the following methods and measures the activity of 10 parts of human serum mAST simultaneously: reaction temperature 37 DEG C, test dominant wavelength 340nm, test commplementary wave length 405nm, tested serum sample/blank with reagent ratio is: sample/compare: reagent 1: reagent 2=18uL:240uL:60uL, reacts for dropping reaction。Method of testing is: sample/comparison first mixes with reagent 1 hatches 5min, add reagent 2 afterwards, reading is started after in 1.5min, and under measuring wavelength, monitor the change of each sample absorbance in 3min continuously, calculate the absorbance changing value △ A/min of average minute clock, and calculate mAST activity value: mAST activity (U/L)=(△ A according to below equationMeasure/min-△ABlank/ min) × F (2840.3)。Measurement result is as shown in table 1。
Table 1mAST detection kit Antibody stability result
By table 1 result it can be seen that be not added with the reagent of antibody stabilization agent after storage 18 months, measured result exceeds about 10% than newly configured reagent, illustrates that the antibody in liquid reagent is deposited 18 months artifact activity and decreased, it is suppressed that ability declines to some extent;And with the addition of the reagent of antibody stabilization agent, the result of mensuration with newly join reagent and remain to keep consistent (± 3%), it was shown that antibody stabilization agent can protect the biological activity of antibody in liquid reagent effectively, improves the stability of antibody。
2, heat stability:
Recipe configuration reagent described in embodiment 1, is placed in heat damage 7d under 37 DEG C of water bath, measures and records the blank absorbency changing value of reagent in 7d, and measure the mAST value of 10 parts of human serum samples in 7d。
Each Blank absorbance values in 37 DEG C of water-bath 7d of table 2mAST detectable
Determination of serum result after 37 DEG C of water-bath 7d of table 3mAST detectable
By table 2 and table 3 result it can be seen that 7d placed by reagent 37 DEG C, blank absorbency is without significant change, and determination of serum result is close to comparison, and result is good。
The people source cAST antibody of the present invention is commercially available prod, such as the GOT1Antibodies that Thermoscientific company sells。
The above embodiment of the present invention is the description of the invention and cannot be used for the restriction present invention, and any change in the implication suitable with claims of the present invention and scope is all considered as being included in the scope of claims。

Claims (4)

1. an aspartate aminotransferase Mitochondria Isoenzyme detection kit, it is characterised in that: this test kit is made up of reagent 1 and 2 two kinds of liquid reagents of reagent, wherein:
Reagent 1:
PH of buffer 6.5 ~ 8.0 0.02 ~ 0.5 mol/L, L-Aspartic acid potassium 0.15 ~ 0.3 mol/L, Malic dehydrogenase 0.3 ~ 5 KU/L, Lactic acid dehydrogenase 0.3 ~ 5 KU/L, People source cAST antibody 5 ~ 20 mL/L, Antibody stabilization agent 0.01 ~ 3 %, Enzyme stabilizers 0.01 ~ 10 %, Preservative 0.01 ~ 1 %,
Reagent 2:
PH of buffer 7.0 ~ 9.0 0.02 ~ 0.5 mol/L, α-ketoglutaric acid 0.005 ~ 0.02 mol/L, Reduced coenzyme Ⅰ 0.1 ~ 0.5 mmol/L, Preservative 0.01 ~ 1 %, Reduced coenzyme Ⅰ stabilizer 0.01 ~ 10 %;
Described antibody stabilization agent is the one in glycine and citric acid, glycine and heparin, citric acid and histidine, heparin and histidine combination;
Described enzyme stabilizers is one or several in trehalose, sucrose, bovine serum albumin, glycerol, Tween 80;
Described reduced coenzyme Ⅰ stabilizer is one or more in trehalose, bovine serum albumin, glycerol, Tween 80。
2. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, it is characterized in that: the described buffer in reagent 1 or 2 is TRIS buffer, piperazine-N, N-double; two (2-hydroxyethanesulfonic acid) buffer, N-2-hydroxyethyl piperazine-N '-ethanesulfonic acid buffer, N-tri-(methylol) methylamino-2-hydroxy-propanesulfonic acid buffer, 4-(2-ethoxy)-1-piperazine propane sulfonic acid buffer, one or more in 3-morpholine-2-hydroxypropionate sodium buffer。
3. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, it is characterised in that: the described combination that antibody stabilization agent is histidine and citric acid。
4. aspartate aminotransferase Mitochondria Isoenzyme detection kit according to claim 1, it is characterised in that: described preservative is NaN3Or the one in proclin300。
CN201410805113.9A 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit Active CN104459158B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410805113.9A CN104459158B (en) 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410805113.9A CN104459158B (en) 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit

Publications (2)

Publication Number Publication Date
CN104459158A CN104459158A (en) 2015-03-25
CN104459158B true CN104459158B (en) 2016-06-22

Family

ID=52905542

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410805113.9A Active CN104459158B (en) 2014-12-22 2014-12-22 Aspartate aminotransferase Mitochondria Isoenzyme detection kit

Country Status (1)

Country Link
CN (1) CN104459158B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104865214A (en) * 2015-05-08 2015-08-26 浙江蓝森生物科技有限公司 Method, reagent and kit for quantitative determination of mitochondrial AST activity in human serum
CN106244671B (en) * 2016-08-30 2020-06-30 山东博科生物产业有限公司 Stable aspartate aminotransferase detects diagnosis detect reagent box
CN107860729B (en) * 2017-11-08 2022-03-11 北京北检·新创源生物技术有限公司 Stable reagent for determining glutamic-oxalacetic transaminase
CN110018305B (en) * 2019-05-12 2020-12-08 武汉生之源生物科技股份有限公司 Aspartate aminotransferase mitochondrial isozyme detection kit and application
CN110079581A (en) * 2019-05-14 2019-08-02 天津中成佳益生物科技有限公司 A kind of detection kit and detection method of aspartate amino transferase Mitochondria Isoenzyme

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769323A (en) * 1984-01-12 1988-09-06 Sawao Murao Method for fractional determination of aspartate aminotransferase isozymes, and composition therefor
CN1546683A (en) * 2003-12-15 2004-11-17 上海北加生化试剂有限公司 Aspartic transaminase mitochondrion isozyme m type measurement method
CN102399851A (en) * 2011-10-25 2012-04-04 宁波美康生物科技有限公司 Sialidase detection kit
CN102946858A (en) * 2010-05-10 2013-02-27 英塔斯生物制药有限公司 Liquid formulation of polypeptides containing an Fc domain of an immunoglobulin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60169766A (en) * 1984-02-14 1985-09-03 Sugiura Shinyaku Kaihatsu Kenkyusho:Kk Reagent for fractional measurement of soluble fraction aspartic acid aminotransferase and mitochondria aspartic acid aminotransferase

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769323A (en) * 1984-01-12 1988-09-06 Sawao Murao Method for fractional determination of aspartate aminotransferase isozymes, and composition therefor
CN1546683A (en) * 2003-12-15 2004-11-17 上海北加生化试剂有限公司 Aspartic transaminase mitochondrion isozyme m type measurement method
CN102946858A (en) * 2010-05-10 2013-02-27 英塔斯生物制药有限公司 Liquid formulation of polypeptides containing an Fc domain of an immunoglobulin
CN102399851A (en) * 2011-10-25 2012-04-04 宁波美康生物科技有限公司 Sialidase detection kit

Also Published As

Publication number Publication date
CN104459158A (en) 2015-03-25

Similar Documents

Publication Publication Date Title
CN104459158B (en) Aspartate aminotransferase Mitochondria Isoenzyme detection kit
CN105203472B (en) A kind of stable free fatty acid determination reagent kit
CN103760357B (en) A kind of ischemia modified albumin IMA detection kit
CN102721684A (en) Two-step enzyme measuring method and measuring reagent for creatinine in blood serum
CN106399460B (en) Kit and method for determining triglycerides
CN102154443A (en) Creatine jubase MB isozyme activity detection reagent and preparation method thereof
CN104359906B (en) A kind of stabilization, the serum tolal bile acid detection reagent of strong antijamming capability
CN102141568A (en) Stable liquid single-reagent blood sugar kit
CN104198420A (en) Stable detection kit of total bile acid
WO2022095576A1 (en) NOVEL N-ACETYL-β-D GLUCOSAMINIDASE DETECTION AGENT
CN110261601B (en) Homocysteine detection kit
CN102128935A (en) Method for detecting hoptoglobin in serum and detecting kit thereof
CN102864206A (en) Anti-heparin interference leucine aminopeptidase measuring reagent
CN102297962A (en) Kit for detecting alkaline phosphatase
Liao et al. Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma
Lane et al. Evaluation of urinary renal biomarkers for early prediction of acute kidney injury following partial nephrectomy: a feasibility study
CN107988315B (en) CK. CKMB, LDH and AST combined detection reagent
CN106404686A (en) Antiheparin serum total bilirubin (vanadate oxidation method) detection kit
CN106244671B (en) Stable aspartate aminotransferase detects diagnosis detect reagent box
CN104865214A (en) Method, reagent and kit for quantitative determination of mitochondrial AST activity in human serum
CN104561237A (en) Blood ammonia kit
US6309816B1 (en) Methods for diagnosing cancer by measuring creatine kinase
CN105223192A (en) A kind of glycated serum protein detects reagent and application thereof
CN103397076B (en) The application in the biochemical reagents of negative value or null value is there is in chlorate in preparation elimination measurement result
CN102010890A (en) Kit for determining mitochondria aspartate aminotransferase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299

Patentee after: Meikang biological Polytron Technologies Inc

Address before: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299

Patentee before: Ningbo Meikang Biotechnology Co., Ltd.

CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Zou Bingde

Inventor after: Zou Jihua

Inventor after: Lu Huixian

Inventor after: Huang Xinglei

Inventor before: Zou Bingde

Inventor before: Zou Jihua

Inventor before: Lu Huixian

Inventor before: Huang Xinlei